American Oncology Network Inc. Reports Over 40% Revenue Growth, Surpassing $2 Billion for 12 Months Ending June 30, 2025

Reuters
Aug 12
<a href="https://laohu8.com/S/AONC">American Oncology Network</a> Inc. Reports Over 40% Revenue Growth, Surpassing $2 Billion for 12 Months Ending June 30, 2025

American Oncology Network Inc. $(AON)$ has reported strong financial results for the 12 months ended June 30, 2025, with annual revenue surpassing $2 billion. This represents a growth of over 40% compared to the previous 12-month period ending June 30, 2024. The increase in revenue is attributed to both organic expansion and the integration of new practices and providers in various markets. AON's provider network has expanded to over 300 oncology and hematology providers across 20 states, enhancing access to advanced treatment options. In terms of business operations, AON continues to invite new partners to join its network, promoting clinical autonomy and increased revenue through access to its comprehensive support infrastructure. Partner practices have experienced an average of more than 30% increase in sustainable income after joining AON. Looking forward, AON has shown leadership in value-based care by achieving nearly $6 million in cost savings for CMS and partnering with a multi-state commercial value-based care organization, resulting in $2.7 million in cumulative savings. Additionally, AON launched a self-funded employer contracting initiative covering 1 million lives, aligned with value-based benefit design principles, and implemented a social risk navigation platform that improved social risk factors by 39%, contributing to better health outcomes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on August 12, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10